Mark Hensley
Corporate Officer/Principal bei VELOXIS PHARMACEUTICALS A/S
Aktive Positionen von Mark Hensley
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| VELOXIS PHARMACEUTICALS A/S | Corporate Officer/Principal | 03.01.2019 | - |
| Vertrieb & Marketing | 01.04.2016 | 03.01.2019 |
Karriereverlauf von Mark Hensley
Ausbildung von Mark Hensley
| University of North Texas | Undergraduate Degree |
Statistik
International
| Dänemark | 2 |
| Vereinigte Staaten | 2 |
Operativ
| Corporate Officer/Principal | 1 |
| Sales & Marketing | 1 |
| Undergraduate Degree | 1 |
Sektoral
| Health Technology | 2 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
Veloxis Pharmaceuticals A/S
 Veloxis Pharmaceuticals A/S Pharmaceuticals: MajorHealth Technology Veloxis Pharmaceuticals A/S is a commercial-stage specialty pharmaceutical company, which engages in the development and commercialization of medicine for the prevention of organ rejection in kidney transplant patients. The company is focused on the direct commercialization of Envarsus XR in the US, expansion of partnerships for markets, and acquisition of assets utilized in transplant patients and by adjacent medical specialties. Veloxis Pharmaceuticals was founded in June 2002 and is headquartered in Copenhagen, Denmark. | Health Technology |
- Börse
- Insiders
- Mark Hensley
- Erfahrung
